相关实验视频

Updated: Jan 18, 2026

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells

Published on: May 9, 2025

三种特定的eFab-eIg T细胞参与者向HER2和HER3

Ann-Kathrin Löffler¹, Annika Huber¹, Monilola A Olayioye^1,2

¹Institute of Cell Biology and Immunology, University of Stuttgart, Stuttgart, Germany.

Frontiers in immunology

|September 12, 2025

概括

研究人员开发了一种用于癌症免疫治疗的新型三种特异抗体平台. 这种创新方法可以创建强大的T细胞参与剂 (TCEs),用于向杀死癌细胞.

科学领域:

生物技术是生物技术.
免疫学免疫学免疫学
在瘤学瘤学.

背景情况:

三特异性抗体通过向复杂的癌症生物学和免疫反应,提供增强的癌症免疫疗法.
现有的抗体技术正在被推进,以创造更有效的癌症治疗方法.

研究的目的:

提出一种使用eIg技术生成三种特异性抗体的新方法.
证明这种方法的可行性,用于创建针对HER2,HER3和CD3.3的T细胞引入器 (TCE).

主要方法:

开发一个不对称的eFab-eIg分子,包括一个Fab和两个eFab部分.
使用两个不同的eFab构建块,对异构EHD2域进行特殊安排.
在二维和三维模型中测试三种特异性TCE的结合活性,T细胞招募和杀死癌细胞的能力.

主要成果:

新的三种特异性抗体设计成功地被证明.
三种特异性T细胞诱导剂 (TCE) 显示保留与HER2,HER3和CD3抗原的结合.
在实验室中观察到有效的T细胞招募和强大的癌细胞杀死.

结论:

模块化架构允许生成具有不同特异性的三种特异性抗体.
这种方法对癌症免疫治疗中的各种应用具有重大潜力.
开发的平台提供了一个多功能工具,用于设计基于抗体的新疗法.

关键词:

CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD4 CD4 CD4 CD4 CD4 CD5 CD5 CD5 CD5 CD5 CD6 CD7 CD7 CD7 CD7 CD7 CD7 CD7 CD7 CD8 CD7 CD8 CD8 CD7 CD8 CD8 CD8 CD8 CD8 CD8 CD8 CD8 CD9 在HER2中,HER2是HER2.在HER3中,HER3是HER3.在T细胞重定位的过程中.抗体工程是针对抗体的工程.这就是EHD2 三种特异性抗体的抗体

更多相关视频

Determining Optimal Cytotoxic Activity of Human Her2neu Specific CD8 T cells by Comparing the Cr51 Release Assay to the xCELLigence System

Determining Optimal Cytotoxic Activity of Human Her2neu Specific CD8 T cells by Comparing the Cr51 Release Assay to the xCELLigence System

Published on: August 8, 2012

Tracking Bispecific Antibody-Induced T Cell Trafficking Using Luciferase-Transduced Human T Cells

Tracking Bispecific Antibody-Induced T Cell Trafficking Using Luciferase-Transduced Human T Cells

Published on: May 12, 2023

相关概念视频

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...